After reaching an important support level, Boston Scientific (BSX) could be a good stock pick from a technical perspective. BSX surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down tren ...

Wall Street analysts forecast that Scholastic (SCHL) will report quarterly earnings of $2.07 per share in its upcoming release, pointing to a year-over-year increase of 13.7%. It is anticipated that revenues will amount to $556.73 million, exhibiting an increase of 2.2% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 7.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration ...

Core Viewpoint - Nutanix reported quarterly earnings of $0.41 per share, matching the Zacks Consensus Estimate, but down from $0.42 per share a year ago [1] - The company posted revenues of $670.58 million for the quarter ended October 2025, missing the Zacks Consensus Estimate by 0.86%, but up from $590.96 million year-over-year [2] Financial Performance - Nutanix has surpassed consensus EPS estimates three times over the last four quarters [2] - The company had a surprise of +15.63% in the previous quarter, with actual earnings of $0.37 per share compared to an expected $0.32 [1][2] - The current consensus EPS estimate for the upcoming quarter is $0.54, with expected revenues of $748.98 million, and for the current fiscal year, the EPS estimate is $1.89 on revenues of $2.92 billion [7] Stock Performance - Nutanix shares have declined approximately 4.7% since the beginning of the year, contrasting with the S&P 500's gain of 14% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Outlook - The Computers - IT Services industry, to which Nutanix belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Nutanix's stock performance [5]

Core Viewpoint - TWFG, Inc. shows a significantly improving earnings outlook, making it a solid choice for investors as analysts continue to raise earnings estimates for the company [1][3]. Estimate Revisions - The rising trend in earnings estimate revisions reflects growing analyst optimism about TWFG's earnings prospects, which is expected to positively influence its stock price [2]. - The Zacks Rank system indicates that stocks with strong earnings estimate revisions tend to outperform, with Zacks 1 Ranked stocks averaging a +25% annual return since 2008 [3]. Current-Quarter Estimate - For the current quarter, TWFG is expected to earn $0.18 per share, representing a year-over-year decline of -5.3%. However, the Zacks Consensus Estimate has increased by 23.08% over the last 30 days due to three upward revisions and no negative revisions [7]. Current-Year Estimate - For the full year, TWFG is projected to earn $0.78 per share, reflecting a +32.2% increase from the previous year. The consensus estimate has risen by 13.93% as four estimates have been revised upward with no negative revisions [8][9]. Zacks Rank - TWFG currently holds a Zacks Rank 2 (Buy), indicating promising estimate revisions that can help investors make informed decisions [10]. Stock Performance - TWFG shares have increased by 9.7% over the past four weeks, suggesting strong investor confidence in its earnings growth prospects [11].

Core Viewpoint - Analysts expect Kohl's to report a quarterly loss of -$0.19 per share, indicating a year-over-year decline of 195% with revenues projected at $3.49 billion, down 5.9% from the previous year [1] Earnings Estimates - Revisions to earnings estimates are crucial for predicting investor actions, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [2] Key Metrics Projections - Analysts predict 'Other revenue' to reach $166.82 million, reflecting a year-over-year change of -17.8% [4] - 'Net Sales' are expected to be $3.32 billion, indicating a decline of -5.2% from the prior-year quarter [4] - 'Revenue Recognition- Accessories' is projected at $670.83 million, suggesting a year-over-year increase of +3.2% [4] - 'Revenue Recognition- Children's' is estimated at $427.08 million, down -12.1% year over year [5] - 'Revenue Recognition- Footwear' is expected to be $274.17 million, indicating a decline of -16.4% from the previous year [5] - 'Revenue Recognition- Men's' is projected at $668.96 million, reflecting a change of -4.6% from the prior-year quarter [6] - 'Revenue Recognition- Women's' is expected to be $832.42 million, indicating a year-over-year change of -4.2% [6] - 'Revenue Recognition- Home' is projected at $443.00 million, reflecting a change of -6.3% from the prior-year quarter [6] Store Metrics - The consensus estimate for the total number of stores stands at 1,153, down from 1,178 in the same quarter last year [7] Stock Performance - Over the past month, Kohl's shares have recorded a return of -7.6%, compared to the Zacks S&P 500 composite's -0.3% change, indicating a performance that aligns with the overall market [7]

Company Performance - Northern Technologies reported a quarterly loss of $0.06 per share, missing the Zacks Consensus Estimate of $0.08, compared to earnings of $0.20 per share a year ago, representing an earnings surprise of -175.00% [1] - The company posted revenues of $22.32 million for the quarter ended August 2025, missing the Zacks Consensus Estimate by 0.38%, and down from $23.35 million year-over-year [2] - Northern Technologies has not surpassed consensus EPS estimates over the last four quarters and has topped consensus revenue estimates only twice in that period [2] Stock Performance - Shares of Northern Technologies have declined approximately 41.1% since the beginning of the year, contrasting with the S&P 500's gain of 13.4% [3] - The current consensus EPS estimate for the upcoming quarter is $0.02 on revenues of $20.7 million, and for the current fiscal year, it is $0.28 on revenues of $89.1 million [7] Industry Outlook - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 9% of over 250 Zacks industries, indicating a challenging environment for the sector [8] - The performance of Northern Technologies may be influenced by the overall outlook for the industry, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Viewpoint - Sera Prognostics, Inc. reported a quarterly loss of $0.16 per share, which was better than the Zacks Consensus Estimate of a loss of $0.19, indicating an earnings surprise of +15.79% [1] Group 1: Earnings Performance - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The quarterly revenue was $0.02 million, missing the Zacks Consensus Estimate by 75.39%, compared to $0.03 million in the same quarter last year [2] - The stock has lost approximately 61.7% since the beginning of the year, while the S&P 500 has gained 16.5% [3] Group 2: Future Outlook - The future performance of Sera Prognostics' stock will depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $0.1 million, and for the current fiscal year, it is -$0.73 on revenues of $0.12 million [7] Group 3: Industry Context - The Medical Services industry, to which Sera Prognostics belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, which may impact the stock's performance [8]

Core Viewpoint - Insulet (PODD) is experiencing solid improvement in earnings estimates, which is likely to positively impact its stock price momentum [1][2]. Earnings Estimate Revisions - The trend in estimate revisions reflects growing analyst optimism regarding Insulet's earnings prospects, which historically correlates with stock price movements [2]. - For the current quarter, Insulet is expected to earn $1.47 per share, representing a year-over-year increase of +27.8%. Over the last 30 days, seven estimates have been revised upward, leading to a 12.07% increase in the Zacks Consensus Estimate [6]. - For the full year, the earnings estimate stands at $4.89 per share, indicating a +50.9% change from the previous year. Eight estimates have moved higher in the past month, resulting in a 6.1% boost to the consensus estimate [7][8]. Zacks Rank and Performance - Insulet currently holds a Zacks Rank 1 (Strong Buy), supported by favorable estimate revisions. This ranking is associated with a strong historical performance, with Zacks 1 stocks averaging a +25% annual return since 2008 [3][9]. - The stock has gained 7.8% over the past four weeks, indicating investor confidence in its earnings growth prospects [10].

Core Viewpoint - Flutter Entertainment reported quarterly earnings of $1.64 per share, significantly exceeding the Zacks Consensus Estimate of $0.13 per share, marking an earnings surprise of +1,161.54% [1] - The company posted revenues of $3.79 billion for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 1.65% [2] Financial Performance - Earnings per share (EPS) for the current quarter was $1.64, compared to $0.43 per share a year ago [1] - Revenue for the quarter was $3.79 billion, up from $3.25 billion year-over-year [2] - Over the last four quarters, Flutter has surpassed consensus EPS estimates four times and topped revenue estimates two times [2] Market Performance - Flutter shares have declined approximately 10.3% since the beginning of the year, while the S&P 500 has gained 16.4% [3] - The current Zacks Rank for Flutter is 4 (Sell), indicating expected underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $2.73 on revenues of $5.37 billion, and for the current fiscal year, it is $8.08 on revenues of $17.06 billion [7] - The gaming industry is currently ranked in the bottom 39% of Zacks industries, which may impact Flutter's stock performance [8]

Core Insights - Bolt Biotherapeutics, Inc. reported a quarterly loss of $3.72 per share, which was better than the Zacks Consensus Estimate of a loss of $5.07, marking an earnings surprise of +26.63% [1] - The company generated revenues of $2.17 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 294.36% and showing an increase from $1.14 million in the same quarter last year [2] - The stock has underperformed, losing approximately 55.1% since the beginning of the year, while the S&P 500 has gained 16.4% [3] Financial Performance - Over the last four quarters, Bolt Biotherapeutics has surpassed consensus EPS estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is -$4.85 on revenues of $0.5 million, and for the current fiscal year, it is -$20.72 on revenues of $4.07 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Bolt Biotherapeutics belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]